NasdaqCM - Delayed Quote USD
Coya Therapeutics, Inc. (COYA)
5.88
+0.18
+(3.16%)
At close: June 6 at 4:00:01 PM EDT
5.86
-0.02
(-0.34%)
After hours: June 6 at 4:04:17 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.41 | -0.4 | -1.64 | -1.75 |
| Low Estimate | -0.43 | -0.43 | -1.72 | -1.93 |
| High Estimate | -0.4 | -0.37 | -1.57 | -1.56 |
| Year Ago EPS | -- | -- | -0.98 | -1.64 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 4 |
| Avg. Estimate | 936k | 4.42M | 5.83M | 462.5k |
| Low Estimate | -- | -- | 258k | -- |
| High Estimate | 4.2M | 8.58M | 9.18M | 1.5M |
| Year Ago Sales | 3.43M | -- | 3.55M | 5.83M |
| Sales Growth (year/est) | -72.67% | 0.00% | 64.06% | -92.07% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.14 | -0.41 | -0.14 | -0.12 |
| EPS Actual | -0.19 | -0.26 | -0.18 | -0.44 |
| Difference | -0.05 | 0.15 | -0.04 | -0.32 |
| Surprise % | -35.71% | 37.35% | -28.57% | -252.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.4 | -1.64 | -1.75 |
| 7 Days Ago | -0.34 | -0.35 | -1.18 | -1.59 |
| 30 Days Ago | -0.34 | -0.35 | -1.18 | -1.59 |
| 60 Days Ago | 0 | 0 | -1.08 | -1.31 |
| 90 Days Ago | 0 | 0 | -1.08 | -1.31 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | 1 |
| Up Last 30 Days | 1 | -- | -- | 1 |
| Down Last 7 Days | 1 | -- | 2 | -- |
| Down Last 30 Days | 1 | -- | 2 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| COYA | -- | -- | -67.86% | -6.08% |
| S&P 500 | 13.13% | 2.48% | 7.55% | 14.01% |
Upgrades & Downgrades
| Maintains | Chardan Capital: Buy to Buy | 5/13/2025 |
| Maintains | Chardan Capital: Buy to Buy | 4/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/24/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/22/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/27/2025 |
| Maintains | Chardan Capital: Buy to Buy | 3/20/2025 |
Related Tickers
GANX Gain Therapeutics, Inc.
1.9200
+1.86%
DNTH Dianthus Therapeutics, Inc.
18.85
+1.51%
FBRX Forte Biosciences, Inc.
11.32
+9.37%
INMB INmune Bio, Inc.
7.62
+3.67%
GLSI Greenwich LifeSciences, Inc.
9.66
+2.44%
ACTU Actuate Therapeutics, Inc. Common stock
8.96
-1.43%
ZLDPY Zealand Pharma A/S
14.39
+0.91%
SOLTF Nxera Pharma Co., Ltd.
7.00
0.00%
CHRO Channel Therapeutics Corporation
1.1397
+6.02%
RNTX Rein Therapeutics Inc.
2.0000
+2.56%